CBPD-268
Product Specifications
Target
PROTACs|||Histone Acetyltransferase
Related Pathways
Chromatin/Epigenetic|||PROTAC
Bioactivity
CBPD-268 is an effective orally active CBP/p300 PROTAC degrader, with a DC50 value of ? 0.03 nM. It induces degradation of CBP/p300 and inhibits cell growth, exhibiting antitumor activity. Additionally, CBPD-268 shows potential for research in AR-positive prostate cancer.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15118389 1 Vial
Lentiviral human SUGP1 shRNA (UAS) - Lentiviral human SUGP1 shRNA (UAS, GFP) (100)
Ask
View Details 
NBP3-24167UV 0.1 mL
Mouse Monoclonal Calbindin D-28K Antibody (FGF2/7365) [DyLight 350]
Ask
View Details